T

The Royal Marsden Hospital | Sutton - GI Lymphoma Research Unit

Research site
(Unclaimed)
Location
Downs Road, Sutton, Sutton, England
Site insights

Top conditions

Prostatic Cancer (5 trials)

Breast Cancer (4 trials)

Adenocarcinoma (4 trials)

Colorectal Cancer (4 trials)

Carcinoma (3 trials)

Top treatments

Afatinib
BIBW 2992
Docetaxel
Oxaliplatin
Bevacizumab
Trastuzumab
Estrogen
Cetuximab
Doxorubicin
Ipatasertib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 41
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

This is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pha...

Active, not recruiting
Bladder Cancer
Melanoma
Drug: Autogene cevumeran
Drug: Atezolizumab

This study will evaluate the safety, pharmacokinetic (PK), pharmacodynamic (PD) activity, and preliminary anti-tumor activity of GDC-9545 as a single...

Active, not recruiting
Breast Cancer
Drug: Palbociclib
Drug: GDC-9545

Primary objective is to assess the anti-tumor activity of single agent odronextamab as measured by the objective response rate (ORR) according to the...

Enrolling
B-cell Non-Hodgkin Lymphoma (NHL)
Drug: Odronextamab

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mC...

Enrolling
Castration-resistant Prostate Cancer
Drug: Pembrolizumab

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems